Estimates Revisions Arecor Therapeutics plc
Stocks
AREC
GB00BMWLM973
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.00 GBX | +2.36% |
|
+2.36% | -19.25% |
| 04-28 | Arecor Therapeutics plc Auditor Raises 'Going Concern' Doubt | CI |
| 04-27 | Arecor Therapeutics plc, 2025 Earnings Call, Apr 23, 2026 |
Turnover - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- AREC Stock
- Consensus Arecor Therapeutics plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
